Drug recall · March 1, 2017
METRONIDazole Injection recall
Why: Lack of Sterility Assurance: customer report of leaking bag
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24
- Lots / codes
Lot: 54-054-JT, 6/1/2017
- Quantity
- 578,784 bags
- Company
- Hospira Inc., A Pfizer Company, Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- February 10, 2017 · Voluntary: Firm initiated
- Classified
- February 17, 2017
- Reported
- March 1, 2017
- Ended
- April 3, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metronidazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.